AbCellera Biologics
ABCL
ABCL
137 hedge funds and large institutions have $434M invested in AbCellera Biologics in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
33% less call options, than puts
Call options by funds: $9.08M | Put options by funds: $13.6M
Holders
137
Holding in Top 10
–
Calls
$9.08M
Puts
$13.6M
Top Buyers
| 1 | +$34.3M | |
| 2 | +$17.1M | |
| 3 | +$9.9M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$9.88M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$9.33M |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$2.8M | |
| 3 | -$2.79M | |
| 4 |
Goldman Sachs
New York
|
-$2.13M |
| 5 |
Jane Street
New York
|
-$1.98M |
